p53 Staining Correlates With Tumor Type and Location in Sebaceous Neoplasms

被引:36
|
作者
Shalin, Sara C. [3 ]
Sakharpe, Aniket [4 ]
Lyle, Stephen [5 ]
Lev, Dina [4 ]
Calonje, Eduardo [6 ]
Lazar, Alexander J. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Sect Dermatopathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[5] Univ Massachusetts, Med Ctr, Dept Canc Biol, Worcester, MA USA
[6] St Thomas Hosp, St Johns Inst Dermatol, London, England
基金
美国国家卫生研究院;
关键词
sebaceous adenoma; sebaceoma; sebaceous carcinoma; p53; Muir-Torre syndrome; DNA mismatch repair; microsatellite instability; MUIR-TORRE-SYNDROME; DNA MISMATCH REPAIR; CELL CARCINOMA; MSH2; MUTATIONS; EXPRESSION; BASAL; DIFFERENTIATION; PHENOTYPE; PROTEINS; ADJACENT;
D O I
10.1097/DAD.0b013e3181ed39f9
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Sebaceous neoplasms are commonly considered in their relationship to the Muir-Torre syndrome and the now well-documented loss of DNA mismatch repair proteins leading to microsatellite instability. However, sebaceous neoplasms showing microsatellite instability comprise only a subset of this group of tumors, and thus, alternative tumorigenic mechanisms must exist. This article explores the relationship of p53, a tumor suppressor implicated in other cutaneous malignancies, and sebaceous neoplasia. We examined 94 sebaceous tumors from 92 patients. Tumors with strong nuclear p53 staining were significantly associated with the diagnosis of sebaceous carcinoma compared with benign sebaceous lesions, most notably for periocular carcinomas. Importantly, nuclear mismatch repair protein expression was intact in all lesions showing p53 alterations, suggesting that p53 dysfunction may represent a divergent pathway in the molecular pathogenesis of these tumors.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 50 条
  • [31] Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling
    Wachter, Franziska
    Grunert, Michaela
    Blaj, Cristina
    Weinstock, David M.
    Jeremias, Irmela
    Ehrhardt, Harald
    CELL COMMUNICATION AND SIGNALING, 2013, 11
  • [32] Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
    Haupt, Sue
    Raghu, Dinesh
    Haupt, Ygal
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [33] UV-Independent p53 Mutations in Sebaceous Carcinoma of the Eyelid
    Hussain, Rehan M.
    Matthews, Jared L.
    Dubovy, Sander R.
    Thompson, Jordan M.
    Wang, Gaofeng
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 30 (05) : 392 - 395
  • [34] p53: not just a tumor suppressor
    Oren, Moshe
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (07) : 539 - 543
  • [35] THE ROLE OF P53 IN TUMOR PROGRESSION
    BLONDAL, JA
    BENCHIMOL, S
    SEMINARS IN CANCER BIOLOGY, 1994, 5 (03) : 177 - 186
  • [36] MUTATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN NEOPLASMS OF THE HUMAN NERVOUS-SYSTEM
    OHGAKI, H
    EIBL, RH
    SCHWAB, M
    REICHEL, MB
    MARIANI, L
    GEHRING, M
    PETERSEN, I
    HOLL, T
    WIESTLER, OD
    KLEIHUES, P
    MOLECULAR CARCINOGENESIS, 1993, 8 (02) : 74 - 80
  • [37] Tumor suppressor p53 and metabolism
    Liu, Juan
    Zhang, Cen
    Hu, Wenwei
    Feng, Zhaohui
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 284 - 292
  • [38] Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern
    Lee, Sang Hwa
    Kim, Hyunkyung
    Kim, Wook Youn
    Han, Hye Seung
    Lim, So Dug
    Kim, Wan Seop
    Kim, Sehun
    Hwang, Tae Sook
    PATHOLOGY INTERNATIONAL, 2013, 63 (05) : 252 - 259
  • [39] Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion
    Zhang, Jin
    Kong, Xiangmudong
    Yang, Hee Jung
    Mohibi, Shakur
    Lucchesi, Christopher August
    Zhang, Weici
    Chen, Xinbin
    CANCERS, 2024, 16 (01)
  • [40] Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
    Lu, Phong
    Vander Mause, Erica R.
    Bowman, Katherine E. Redd
    Brown, Sarah M.
    Ahne, Lisa
    Lim, Carol S.
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)